SWTX
SpringWorks Therapeutics
SWTX
SWTX
Delisted
SWTX was delisted on the 30th of June, 2025.
148 hedge funds and large institutions have $1.7B invested in SpringWorks Therapeutics in 2023 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 55 increasing their positions, 46 reducing their positions, and 14 closing their positions.
Holders
148
Holders Change
+11
Holders Change %
+8.03%
% of All Funds
2.37%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.08%
New
25
Increased
55
Reduced
46
Closed
14
Calls
$6.88M
Puts
$111K
Net Calls
+$6.77M
Net Calls Change
-$11.7M
Top Buyers
Top Sellers
1 |
BCLSI
1
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
$79.3M |
2 |
2
State Street
Boston,
Massachusetts
|
$72.4M |
3 |
O
3
OrbiMed
New York
|
$116M |
4 |
PA
4
Perceptive Advisors
New York
|
$53.5M |
5 |
5
Barclays
London,
United Kingdom
|
$16.9M |